Correction to “Impact analysis of heart failure across European countries: an ESC‐HFA position paper” and “Echocardiographically defined haemodynamic categorization predicts prognosis in ambulatory heart failure patients treated with sacubitril/valsartan”
Abstract
Genes, proteins, chemicals, diseases, species, mutations and cell lines named across the full text — each resolved to its canonical identifier and authoritative record.
Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsHeart Failure Treatment and Management · Cardiac pacing and defibrillation studies · Cardiovascular Function and Risk Factors
Massimo Piepoli's affiliations was incorrect.
It should have read:
- Department of Biomedical Science for Health, University of Milan, Via Festa del Perdono 7, 20122 Milan, Italy
- Clinical Cardiology, IRCCS Policlinico San Donato, Via Morandi 30, 20097 San Donato Milanese, Milan, Italy
The affected articles are listed in the reference list.1, 2
We apologize for these errors.
The reference list from the paper itself. Each links out to its DOI / PubMed record.
- 1Rosano GMC , Seferovic P , Savarese G , Spoletini I , Lopatin Y , Gustafsson F , et al. Impact analysis of heart failure across European countries: An ESC‐HFA position paper. ESC Heart Fail 2022;9:2767‐2778. doi:10.1002/ehf 2.14076 35869679 PMC 9715845 · doi ↗ · pubmed ↗
- 2Dini FL , Carluccio E , Bitto R , Ciccarelli M , Correale M , D'Agostino A , et al. Working Group on Heart Failure of the Italian Society of Cardiology. Echocardiographically defined haemodynamic categorization predicts prognosis in ambulatory heart failure patients treated with sacubitril/valsartan. ESC Heart Fail 2022;9:1107‐1117. doi:10.1002/ehf 2.13779 35122477 PMC 8934975 · doi ↗ · pubmed ↗